| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.08 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.09 |